Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures-Reference-Cited by-同舟云学术

Everolimus dosing recommendations for tuberous sclerosis complex-associated refractory seizures

Published:2018-05-04 Issue:6 Volume:59 Page:1188-1197
ISSN:0013-9580
Container-title:Epilepsia
language:en
Short-container-title:Epilepsia

Author:

Franz David N.¹,Lawson John A.²,Yapici Zuhal³,Brandt Christian⁴^ORCID,Kohrman Michael H.⁵,Wong Michael⁶,Milh Mathieu⁷,Wiemer-Kruel Adelheid⁸,Voi Maurizio⁹,Coello Neva¹⁰,Cheung Wing⁹,Grosch Kai¹⁰,French Jacqueline A.¹¹

Affiliation:

1. Department of Neurology; Cincinnati Children's Hospital Medical Center; Cincinnati OH USA

2. Tuberous Sclerosis Multidisciplinary Management Clinic; Sydney Children's Hospital; Randwick New South Wales Australia

3. Division of Child Neurology; Department of Neurology; Istanbul Faculty of Medicine; Istanbul University; Istanbul Turkey

4. Bethel Epilepsy Center; Mara Hospital; Bielefeld Germany

5. NeuroDevelopmental Science Center; University of Chicago; Chicago IL USA

6. Department of Neurology; Washington University School of Medicine; St. Louis MO USA

7. Pediatric Neurology Service; Aix-Marseille University; Marseille France

8. Epilepsy Center Kork/TSC Center; Kehl-Kork Germany

9. Novartis Pharmaceuticals Corporation; East Hanover NJ USA

10. Novartis Pharmaceuticals AG; Basel Switzerland

11. New York University Comprehensive Epilepsy Center; New York NY USA

Funder

Novartis Pharmaceuticals Corporation

Nutricia Research Foundation

UCB

Desitin

Epilepsy Foundation

Acorda

Adamas

Alexza

Anavex

Axcella Health

Biogen

BioPharm Solutions

Cerecor

Pharmaceuticals

Engage

Eisai

GlaxoSmithKline

GW Pharma

Marinus

Nestle Health Science

Neurelis

Pfizer

Otzuka

Ovid

Sage Therapeutics

SK Life Sciences

Sunovion

Takeda

Upsher-Smith

Xenon Pharmaceuticals

Zogenix

Zynerba

Eisai Medical Research

LCGH

Lundbeckfonden

Epilepsy Research Foundation

Epilepsy Study Consortium

Epilepsy Therapy Project

National Institute of Neurological Disorders and Stroke

Publisher

Wiley

Subject

Neurology (clinical),Neurology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/epi.14085/fullpdf

Reference20 articles.

1. The tuberous sclerosis complex;Crino;N Engl J Med,2006

2. Tuberous sclerosis: epidemiology, genetics and progress towards treatment;Morrison;Neuroepidemiology,2009

3. The natural history of epilepsy in tuberous sclerosis complex;Chu-Shore;Epilepsia,2010

4. Neurological and neuropsychiatric aspects of tuberous sclerosis complex;Curatolo;Lancet Neurol,2015

5. Optimal management of seizures associated with tuberous sclerosis complex: current and emerging options;Wang;Neuropsychiatr Dis Treat,2014

Cited by 44 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Potential roles of voltage-gated ion channel disruption in Tuberous Sclerosis Complex;Frontiers in Molecular Neuroscience;2024-08-26

2. Pharmacokinetic variability of everolimus and impact of concomitant antiseizure medications in patients with tuberous sclerosis complex: A retrospective study of therapeutic drug monitoring data in Denmark and Norway;Medicine;2024-08-09

3. Preventative treatment of tuberous sclerosis complex with sirolimus: Phase I safety and efficacy results;Annals of the Child Neurology Society;2024-04-22

4. Targeted suppression of mTORC2 reduces seizures across models of epilepsy;Nature Communications;2023-11-14

5. Neurofibromatosis type1, type 2, tuberous sclerosis and Von Hippel-Lindau disease;Child's Nervous System;2023-10